Literature DB >> 10217414

Effects of IL-1 receptor-associated kinase (IRAK) expression on IL-1 signaling are independent of its kinase activity.

J Knop1, M U Martin.   

Abstract

Interleukin-1 (IL-1) stimulates the association of the IL-1 receptor-associated protein kinase (IRAK) with the heterodimer of IL-IRI and IL-IRAcP via the adapter protein MyD88. In the receptor complex IRAK becomes heavily phosphorylated and concomitantly activated. Here we show that overexpression of a kinase-inactive mutant of IRAK (K239S) inhibits neither IL-1-stimulated activation of the transcription factor NF-kappaB, nor that of the c-Jun N-terminal kinase nor IL-2 production in murine EL-4 cells, but enhances these effects in a manner comparable to wild type IRAK. This strongly suggests that the intrinsic kinase activity is not required for downstream signaling via IRAK.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217414     DOI: 10.1016/s0014-5793(99)00322-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase.

Authors:  Shyun Li; Astrid Strelow; Elizabeth J Fontana; Holger Wesche
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription.

Authors:  M Bonnard; C Mirtsos; S Suzuki; K Graham; J Huang; M Ng; A Itié; A Wakeham; A Shahinian; W J Henzel; A J Elia; W Shillinglaw; T W Mak; Z Cao; W C Yeh
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

3.  A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK).

Authors:  Ken Yanagisawa; Kenji Tago; Morisada Hayakawa; Motomichi Ohki; Hiroyuki Iwahana; Shin-Ichi Tominaga
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

4.  Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.

Authors:  Anil K Singh; Sadiq Umar; Sharayah Riegsecker; Mukesh Chourasia; Salahuddin Ahmed
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

5.  Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.

Authors:  Jedediah Seltzer; Razia Moorad; Jason M Schifano; Justin T Landis; Dirk P Dittmer
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

6.  Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway.

Authors:  G Takaesu; J Ninomiya-Tsuji; S Kishida; X Li; G R Stark; K Matsumoto
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

7.  Lipopolysaccharide-induced activation of beta2-integrin function in macrophages requires Irak kinase activity, p38 mitogen- activated protein kinase, and the Rap1 GTPase.

Authors:  A Schmidt; E Caron; A Hall
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 8.  Pathogenesis of human B cell lymphomas.

Authors:  Arthur L Shaffer; Ryan M Young; Louis M Staudt
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

9.  Pathways regulating lipopolysaccharide-induced neutrophil survival revealed by lentiviral transduction of primary human neutrophils.

Authors:  Emily P Dick; Lynne R Prince; Elizabeth C Prestwich; Stephen A Renshaw; Moira K B Whyte; Ian Sabroe
Journal:  Immunology       Date:  2008-10-28       Impact factor: 7.397

10.  Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.

Authors:  Dietrich B Conze; Chuan-Jin Wu; James A Thomas; Allison Landstrom; Jonathan D Ashwell
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.